Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$2.08B |
| 2 |
Microsoft
MSFT
|
+$699M |
| 3 |
Exxon Mobil
XOM
|
+$614M |
| 4 |
Apple
AAPL
|
+$587M |
| 5 |
UnitedHealth
UNH
|
+$448M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$1.1B |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$477M |
| 3 |
GE Aerospace
GE
|
+$375M |
| 4 |
AEL
American Equity Investment Life Holding Company
AEL
|
+$271M |
| 5 |
Applied Materials
AMAT
|
+$209M |
Sector Composition
| 1 | Technology | 20.72% |
| 2 | Financials | 16.94% |
| 3 | Industrials | 12.24% |
| 4 | Consumer Discretionary | 10.5% |
| 5 | Healthcare | 10% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Li Auto
LI
$24.6B
| $8.5M | ﹤0.01% |
475,303
-14,602
| -3% | -$261K |
|
2327
QuantumScape
QS
$5.07B
| $8.49M | ﹤0.01% |
1,726,158
-92,432
| -5% | -$455K |
|
2328
Friedman Industries
FRD
$152M
| $8.48M | ﹤0.01% |
561,702
+1,591
| +0.3% | +$24K |
|
2329
Stitch Fix
SFIX
$766M
| $8.48M | ﹤0.01% |
2,042,924
-339,743
| -14% | -$1.41M |
|
2330
AnaptysBio
ANAB
$648M
| $8.42M | ﹤0.01% |
335,934
-133,926
| -29% | -$3.36M |
|
2331
Edgewise Therapeutics
EWTX
$1.53B
| $8.42M | ﹤0.01% |
467,507
+168,219
| +56% | +$3.03M |
|
2332
Kewaunee Scientific
KEQU
$139M
| $8.38M | ﹤0.01% |
177,548
+6,132
| +4% | +$289K |
|
2333
Crawford & Co Class A
CRD.A
$533M
| $8.37M | ﹤0.01% |
968,933
-12,165
| -1% | -$105K |
|
2334
argenx
ARGX
$46.5B
| $8.34M | ﹤0.01% |
19,388
+1,438
| +8% | +$618K |
|
2335
Haleon
HLN
$44.2B
| $8.32M | ﹤0.01% |
1,007,458
+24,673
| +3% | +$204K |
|
2336
Parke Bancorp
PKBK
$268M
| $8.31M | ﹤0.01% |
477,549
+22,374
| +5% | +$389K |
|
2337
HBT Financial
HBT
$815M
| $8.3M | ﹤0.01% |
406,456
+26,135
| +7% | +$534K |
|
2338
Forrester Research
FORR
$188M
| $8.2M | ﹤0.01% |
480,044
-65,065
| -12% | -$1.11M |
|
2339
Cytek Biosciences
CTKB
$510M
| $8.17M | ﹤0.01% |
1,465,122
+89,615
| +7% | +$500K |
|
2340
Skyward Specialty Insurance
SKWD
$1.92B
| $8.15M | ﹤0.01% |
+225,280
| New | +$8.15M |
|
|
GOOD
2341
Gladstone Commercial Corp
GOOD
$607M
| $8.1M | ﹤0.01% |
567,878
+14,452
| +3% | +$206K |
|
2342
Televisa
TV
$1.46B
| $8.08M | ﹤0.01% |
2,915,731
-30,005
| -1% | -$83.1K |
|
2343
Cytokinetics
CYTK
$6.36B
| $8.05M | ﹤0.01% |
148,561
+32,372
| +28% | +$1.75M |
|
2344
Sasol
SSL
$4.53B
| $7.97M | ﹤0.01% |
1,047,270
-14,490
| -1% | -$110K |
|
2345
Jakks Pacific
JAKK
$196M
| $7.96M | ﹤0.01% |
444,488
+102,155
| +30% | +$1.83M |
|
|
GMRE
2346
Global Medical REIT
GMRE
$512M
| $7.93M | ﹤0.01% |
872,996
+6,676
| +0.8% | +$60.6K |
|
2347
Artesian Resources
ARTNA
$339M
| $7.93M | ﹤0.01% |
225,400
-7,613
| -3% | -$268K |
|
|
MODV
2348
DELISTED
ModivCare
MODV
| $7.91M | ﹤0.01% |
301,633
-48,936
| -14% | -$1.28M |
|
2349
The RMR Group
RMR
$288M
| $7.91M | ﹤0.01% |
349,912
-7,408
| -2% | -$167K |
|
2350
AstroNova
ALOT
$75.2M
| $7.89M | ﹤0.01% |
510,969
-2,892
| -0.6% | -$44.7K |
|